BMRN Financial Facts
Interest income: 1.63MSelling, general and administrative: 118.76M
See Full Income Statement
Other long-term liabilities: 43.27M
Total assets: 3.84B
See Full Balance Sheet
BioMarin Pharmaceutical Inc. (BMRN) Earnings
|
Expand Research on BMRN
| Next EPS Date | 4/24/24 | EPS Growth Rate | -45.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +141.4% | Revenue Growth Rate | +8.9% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/16  |
 |
Q216 | -$2.61 | -$0.52 | -$2.09 | $300.1M | $278.16M |  |
 | | Details |
| 2/25/16 |
|
Q415 | $0.39 | $0.99 | -$0.60 | $227.9M | $224.38M | |
| | Details |
| 4/24/24 |
Q124 | N/A | $0.33 | N/A | N/A | $649.46M | = | N/A | N/A | ||
| 2/21/13 |
|
Q412 | -$0.43 | -$0.27 | -$0.16 | $130.96M | $129.7M | = | | | Details |
| 2/23/17 | |
Q416 | -$0.53 | -$0.38 | -$0.15 | $300M | $295.96M | = | | | Details |
| 4/25/19 | |
Q119 | -$0.32 | -$0.18 | -$0.14 | $400M | $389.69M | = | | | Details |
| 2/16/12 |
|
Q411 | -$0.23 | -$0.11 | -$0.12 | $107.9M | $115.3M | = | | | Details |
| 8/1/19 | |
Q219 | -$0.21 | -$0.10 | -$0.11 | $387.8M | $415.04M | = | | | Details |
